| |
Matrixx Initiatives Inc. (MTXX)
|
| Last Traded At: |
$4.92
+
$0.16
|
| Volume: |
121,522 |
| Price/Earnings: |
$0.00 |
| Earnings Per Share: |
($1.20) |
| 52 Week High: |
$19.74 |
| 52 Week Low: |
$3.61 |
 |
| StockSpiker Coverage & Performance |
|
This stock has been covered by StockSpiker on the following dates. In addition, the percentage change from the coverage date and today's price is shown.
|
| Coverage |
Coverage
Date |
Gain Since Then |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| About Matrixx Initiatives Inc. |
| We develop, produce, market and sell innovative, over-the-counter
(OTC) healthcare products with an emphasis on those that utilize unique, novel
and/or proprietary delivery systems that provide consumers with "Better Ways to
Get Better ." Through our subsidiary, Zicam, LLC, we produce, market and sell
products under the Zicam and Nasal Comfort™ brands. As discussed in more detail
below, our current product offerings compete in the following four product
classes: Cold Remedy; Allergy/Sinus; Cough; and Multi-Symptom Cold/Flu relief.
Cold Remedy. Zicam Cold Remedy nasal gel is a patented, homeopathic remedy that
has been clinically proven to reduce the duration and severity of the common
cold. The nasal delivery forms are available in a no-drip pump or our patented
nasal swab unit dose package. |
 |
|
This website is intended to provide information only. If you are seeking advice on any matters relating to information on this website, you should - where appropriate - contact your broker or investment manager directly with your specific questions or seek advice from qualified Professional Financial advisor.
Whether you are a technical daytrader, or a long term fundamental investor, the StockSpiker gives you investment ideas based on the most relevant recent price
history of stocks. Here are some recent movers that we have reported on:
|
| |